Convalescent Plasma News and Research

RSS
FDA issues emergency use authorization for convalescent plasma in COVID-19

FDA issues emergency use authorization for convalescent plasma in COVID-19

Equine antibody preparation shows greater capacity to neutralize SARS-CoV-2 isolate than human convalescent plasma

Equine antibody preparation shows greater capacity to neutralize SARS-CoV-2 isolate than human convalescent plasma

VUMC receives $34 million grant for nationwide convalescent plasma study

VUMC receives $34 million grant for nationwide convalescent plasma study

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Preliminary Mayo Clinic results from convalescent plasma in 35,322 patients

Preliminary Mayo Clinic results from convalescent plasma in 35,322 patients

De novo designed SARS-CoV-2 nanoparticle vaccine

De novo designed SARS-CoV-2 nanoparticle vaccine

Study of 300 COVID-19 patients shows efficacy of convalescent plasma therapy

Study of 300 COVID-19 patients shows efficacy of convalescent plasma therapy

Bereaved families are ‘the secondary victims of COVID-19’

Bereaved families are ‘the secondary victims of COVID-19’

Research looks at convalescent plasma use in COVID-19 mouse model

Research looks at convalescent plasma use in COVID-19 mouse model

COVID-19 should be treated as an acute inflammatory disease, Massey scientist says

COVID-19 should be treated as an acute inflammatory disease, Massey scientist says

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

Pitt collaborative receives $7 million to evaluate convalescent plasma therapy for COVID-19

Pitt collaborative receives $7 million to evaluate convalescent plasma therapy for COVID-19

South Texas Blood & Tissue Center marks three months of using Biolog-id's solution for COVID-19

South Texas Blood & Tissue Center marks three months of using Biolog-id's solution for COVID-19

New tools developed to test the ability of anti-coronavirus antibodies

New tools developed to test the ability of anti-coronavirus antibodies

New assay improves detection of SARS-CoV-2 antibodies

New assay improves detection of SARS-CoV-2 antibodies

Researchers are producing COVID-19 spike proteins to prevent future infections

Researchers are producing COVID-19 spike proteins to prevent future infections

Children with MIS-C have different antibody responses than adults with COVID-19

Children with MIS-C have different antibody responses than adults with COVID-19

Llama nanobodies block SARS-CoV-2 infection in vitro

Llama nanobodies block SARS-CoV-2 infection in vitro

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.